ClinicalTrials.govpublic full text
Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma
lymphoma leukemia, car-t cell, cd19, lymphoma, leukemia, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896152
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.